| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▲ | 1.04▲ | 1.04▼ | 1.06▼ | 1.06▼ |
| MA10 | 1.05▼ | 1.05▼ | 1.05▼ | 1.05▼ | 1.23▼ |
| MA20 | 1.05▼ | 1.05▼ | 1.05▼ | 1.06▼ | 1.14▼ |
| MA50 | 1.05▼ | 1.06▼ | 1.05▼ | 1.23▼ | 1.14▼ |
| MA100 | 1.06▼ | 1.14▼ | 1.26▼ | 1.14▼ | 1.60▼ |
| MA200 | 1.18▼ | 1.35▼ | 1.30▼ | 1.12▼ | 2.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.002▼ | 0.000▼ | 0.008▲ | -0.016▼ |
| RSI | 46.159▼ | 46.136▼ | 45.291▼ | 42.036▼ | 46.501▼ |
| STOCH | 17.273▼ | 23.939 | 42.088 | 77.856 | 18.343▼ |
| WILL %R | -63.636 | -63.636 | -53.846 | -44.444 | -89.522▼ |
| CCI | -65.507 | -86.084 | -43.121 | -81.302 | -83.189 |
| CDL | $ENLV Doji Candlestick Pattern Detected | Set Alert |
|
Sunday, September 14, 2025 07:39 AM
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...
|
|
Thursday, September 11, 2025 05:18 AM
Allocetra™ demonstrated statistically significant and clinically meaningful improvements in pain and function in Phase IIa trial in primary ...
|
|
Tuesday, September 09, 2025 06:20 AM
Enlivex recently reported positive three-month topline data from the Phase IIa stage of ENX-CL-05-001, a multi-center, two-stage Phase I/II double-blind, randomized, placebo-controlled clinical trial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/09/25 | 1.05 | 1.05 | 1.01 | 1.05 | 160,400 |
| 17/09/25 | 1.08 | 1.09 | 1.03 | 1.05 | 134,900 |
| 16/09/25 | 1.07 | 1.08 | 1.05 | 1.08 | 129,645 |
| 15/09/25 | 1.07 | 1.0801 | 1.05 | 1.065 | 143,969 |
| 12/09/25 | 1.05 | 1.08 | 1.05 | 1.07 | 199,780 |
| 11/09/25 | 1.03 | 1.08 | 1.03 | 1.07 | 289,441 |
| 10/09/25 | 1.03 | 1.04 | 1.00 | 1.015 | 235,100 |
| 09/09/25 | 1.04 | 1.05 | 1.01 | 1.03 | 183,842 |
| 08/09/25 | 1.07 | 1.076 | 1.04 | 1.04 | 254,600 |
| 05/09/25 | 1.06 | 1.08 | 1.05 | 1.06 | 175,593 |
|
|
||||
|
|
||||
|
|